Wearables like the ones Huawei (and many other brands) make are designed for tracking. As much as possible, really. The Watch GT 6 Pro is about to get one more tracking feature, thanks to something the Chinese company calls Diabetes Risk Study.
Announced at the World Health Expo in Dubai, the “24/7 blood sugar monitoring feature” has launched for the GT 6 Pro and Huawei’s rather more unusual Watch D2. The latter device also features blood-pressure monitoring as its main function.
Huawei avoiding diabetes
View this post on Instagram
Using a health expo and Instagram as the main avenues for announcing a new feature is an unusual step, but whatever gets the job done, we suppose. It uses the device’s photoplethysmography (a word we’re never going to attempt to pronounce) tech, plus feedback from other onboard sensors to perform non-invasive glucose monitoring. How well it works remains to be seen, but Huawei obviously reckons it’s fantastic.
Measurement takes between three and fourteen days of constant monitoring. Conveniently, the latter is at the upper limit of the Watch GT 6 Pro’s battery life. Once it’s done measuring — rest heart-rate plays a large role, apparently — users are given a rating. A result of either Low, Medium, or High is obtained. If it’s medium or high risk, the watch’s software will advise wearers to consult a doctor.
It’s not just the Watch GT 6 Pro getting some anti-diabetes action. Other, unspecified models will also get the feature at a later date.
